Compare MD & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MD | OPK |
|---|---|---|
| Founded | 1979 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.0B |
| IPO Year | 1995 | 1995 |
| Metric | MD | OPK |
|---|---|---|
| Price | $22.26 | $1.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $21.00 | $2.28 |
| AVG Volume (30 Days) | 1.1M | ★ 2.8M |
| Earning Date | 11-03-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.91 | N/A |
| Revenue | ★ $1,922,442,000.00 | $642,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.70 | N/A |
| P/E Ratio | $11.79 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.84 | $1.11 |
| 52 Week High | $24.99 | $2.04 |
| Indicator | MD | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 52.93 |
| Support Level | $21.10 | $1.28 |
| Resistance Level | $24.99 | $1.35 |
| Average True Range (ATR) | 0.79 | 0.05 |
| MACD | -0.39 | 0.01 |
| Stochastic Oscillator | 30.08 | 68.30 |
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.